Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 164

1.

Usefulness of a standard 12-lead electrocardiogram to predict the eligibility for a subcutaneous defibrillator.

Sakhi R, Theuns DAMJ, Cosgun D, Michels M, Schinkel AFL, Kauling RM, Roos-Hesselink JW, Yap SC.

J Electrocardiol. 2019 Jul - Aug;55:123-127. doi: 10.1016/j.jelectrocard.2019.05.014. Epub 2019 May 24.

2.

Trends in time in the management of the implantable cardioverter defibrillator in the last phase of life: a retrospective study of medical records.

Stoevelaar R, Brinkman-Stoppelenburg A, van Driel AG, Theuns DA, Bhagwandien RE, van Bruchem-Visser RL, Lokker IE, van der Heide A, Rietjens JA.

Eur J Cardiovasc Nurs. 2019 Aug;18(6):449-457. doi: 10.1177/1474515119844660. Epub 2019 Apr 17.

PMID:
30995145
3.

Patient-Reported Quality of Life as a Predictor of Mortality and Ventricular Tachyarrhythmia's During 7 Years' Follow-Up in Patients With an Implantable Cardioverter Defibrillator (from the MIDAS Study).

van Veen B, Andersen CM, Johansen JB, Theuns DA, Pedersen SS.

Am J Cardiol. 2019 Feb 15;123(4):605-610. doi: 10.1016/j.amjcard.2018.11.021. Epub 2018 Nov 24.

PMID:
30553508
4.

Insertable cardiac monitors: current indications and devices.

Sakhi R, Theuns DAMJ, Szili-Torok T, Yap SC.

Expert Rev Med Devices. 2019 Jan;16(1):45-55. doi: 10.1080/17434440.2018.1557046. Epub 2018 Dec 11. Review.

PMID:
30522350
5.

Predictors for early mortality and arrhythmic events in patients with a CRT-D: A two center cohort study.

Gunten SV, Theuns DA, Kühne M, Reichlin T, Sticherling C, Schaer B.

Cardiol J. 2018 Nov 28. doi: 10.5603/CJ.a2018.0144. [Epub ahead of print]

6.

Evaluation of recurrent ventricular tachyarrhythmias in patients who survived out-of-hospital cardiac arrest due to ventricular fibrillation: eligibility for subcutaneous implantable defibrillator therapy.

Theuns DAMJ, Bhagwandien RE, Szili-Torok T, Zijlstra F, Yap SC.

J Interv Card Electrophysiol. 2019 Sep;55(3):317-323. doi: 10.1007/s10840-018-0490-4. Epub 2018 Nov 26.

PMID:
30478809
7.

Atrial fibrillation reduction by renal sympathetic denervation: 12 months' results of the AFFORD study.

Feyz L, Theuns DA, Bhagwandien R, Strachinaru M, Kardys I, Van Mieghem NM, Daemen J.

Clin Res Cardiol. 2019 Jun;108(6):634-642. doi: 10.1007/s00392-018-1391-3. Epub 2018 Nov 10.

8.

Frequency of Need for Antitachycardia or Antibradycardia Pacing or Cardiac Resynchronization Therapy in Patients With a Single-Chamber Implantable Cardioverter-Defibrillator.

Melles MC, Yap SC, Bhagwandien RE, Sakhi R, Szili-Torok T, Theuns DAMJ.

Am J Cardiol. 2018 Dec 15;122(12):2068-2074. doi: 10.1016/j.amjcard.2018.08.059. Epub 2018 Sep 23.

PMID:
30340766
9.

Psychological distress in patients with an implantable cardioverter defibrillator and their partners.

Rottmann N, Skov O, Andersen CM, Theuns DAMJ, Pedersen SS.

J Psychosom Res. 2018 Oct;113:16-21. doi: 10.1016/j.jpsychores.2018.07.010. Epub 2018 Jul 20.

PMID:
30190043
10.

Evaluation of a novel automatic screening tool for determining eligibility for a subcutaneous implantable cardioverter-defibrillator.

Sakhi R, Yap SC, Michels M, Schinkel AFL, Kauling RM, Roos-Hesselink JW, Theuns DAMJ.

Int J Cardiol. 2018 Dec 1;272:97-101. doi: 10.1016/j.ijcard.2018.07.037. Epub 2018 Jul 6.

PMID:
30005832
11.

The incidence and impact of implantable cardioverter defibrillator shocks in the last phase of life: An integrated review.

Stoevelaar R, Brinkman-Stoppelenburg A, Bhagwandien RE, van Bruchem-Visser RL, Theuns DA, van der Heide A, Rietjens JA.

Eur J Cardiovasc Nurs. 2018 Aug;17(6):477-485. doi: 10.1177/1474515118777421. Epub 2018 May 18. Review.

12.

Nationwide Longitudinal Follow-Up of Riata Leads Under Advisory at 3 Annual Screenings: Report From the Netherlands Heart Rhythm Association Device Advisory Committee.

Theuns DAMJ, van Erven L, Kimman GP, de Cock CC, Elvan A, Alings MA, van Opstal J, Meine M.

JACC Clin Electrophysiol. 2017 Aug;3(8):887-893. doi: 10.1016/j.jacep.2016.12.011. Epub 2017 Mar 1.

13.

Prospective blinded evaluation of a novel sensing methodology designed to reduce inappropriate shocks by the subcutaneous implantable cardioverter-defibrillator.

Theuns DAMJ, Brouwer TF, Jones PW, Allavatam V, Donnelley S, Auricchio A, Knops RE, Burke MC.

Heart Rhythm. 2018 Oct;15(10):1515-1522. doi: 10.1016/j.hrthm.2018.05.011. Epub 2018 Jun 8.

14.

Procedural and long-term outcome after catheter ablation of idiopathic outflow tract ventricular arrhythmias: comparing manual, contact force, and magnetic navigated ablation.

de Vries LJ, Hendriks AA, Yap SC, Theuns DAMJ, van Domburg RT, Szili-Torok T.

Europace. 2018 May 1;20(suppl_2):ii22-ii27. doi: 10.1093/europace/euy004.

PMID:
29722857
15.

Conduction dynamics after transcatheter aortic valve implantation and implications for permanent pacemaker implantation and early discharge: the CONDUCT-study.

van Gils L, Baart S, Kroon H, Rahhab Z, El Faquir N, Rodriguez Olivares R, Aga Y, Maugenest AM, Theuns DA, Boersma E, Szili Torok T, De Jaegere PP, Van Mieghem NM.

Europace. 2018 Dec 1;20(12):1981-1988. doi: 10.1093/europace/euy074.

PMID:
29688322
16.

Six-year follow-up of the initial Dutch subcutaneous implantable cardioverter-defibrillator cohort: Long-term complications, replacements, and battery longevity.

Quast ABE, van Dijk VF, Yap SC, Maass AH, Boersma LVA, Theuns DA, Knops RE.

J Cardiovasc Electrophysiol. 2018 Jul;29(7):1010-1016. doi: 10.1111/jce.13498. Epub 2018 Apr 20.

PMID:
29626366
17.

Value of implantable loop recorders in patients with structural or electrical heart disease.

Sakhi R, Theuns DAMJ, Bhagwandien RE, Michels M, Schinkel AFL, Szili-Torok T, Zijlstra F, Roos-Hesselink JW, Yap SC.

J Interv Card Electrophysiol. 2018 Jul;52(2):203-208. doi: 10.1007/s10840-018-0354-y. Epub 2018 Mar 13.

18.

Increased risk of ventricular arrhythmias in survivors of out-of-hospital cardiac arrest with chronic total coronary occlusion.

Yap SC, Sakhi R, Theuns DAMJ, Yasar YE, Bhagwandien RE, Diletti R, Zijlstra F, Szili-Torok T.

Heart Rhythm. 2018 Jan;15(1):124-129. doi: 10.1016/j.hrthm.2017.09.004. Epub 2017 Sep 14.

PMID:
28917556
19.

Dutch outcome in implantable cardioverter-defibrillator therapy (DO-IT): registry design and baseline characteristics of a prospective observational cohort study to predict appropriate indication for implantable cardioverter-defibrillator.

van Barreveld M, Dijkgraaf MGW, Hulleman M, Boersma LVA, Delnoy PPHM, Meine M, Tuinenburg AE, Theuns DAMJ, van der Voort PH, Kimman GP, Buskens E, Tijssen JPG, Bruinsma N, Verstraelen TE, Zwinderman AH, van Dessel PHFM, Wilde AAM; DO-IT investigators.

Neth Heart J. 2017 Oct;25(10):574-580. doi: 10.1007/s12471-017-1016-x.

20.

Prolonged Right Ventricular Ejection Delay in Brugada Syndrome Depends on the Type of SCN5A Variant - Electromechanical Coupling Through Tissue Velocity Imaging as a Bridge Between Genotyping and Phenotyping.

Van Malderen SCH, Daneels D, Kerkhove D, Peeters U, Theuns DAMJ, Droogmans S, Van Camp G, Weytjens C, Biervliet M, Bonduelle M, Van Dooren S, Brugada P.

Circ J. 2017 Dec 25;82(1):53-61. doi: 10.1253/circj.CJ-16-1279. Epub 2017 Aug 4.

21.

Remote monitoring of heart failure: benefits for therapeutic decision making.

Martirosyan M, Caliskan K, Theuns DAMJ, Szili-Torok T.

Expert Rev Cardiovasc Ther. 2017 Jul;15(7):503-515. doi: 10.1080/14779072.2017.1348229. Epub 2017 Jul 6. Review.

PMID:
28656875
22.

Type and rate of atrial fibrillation termination due to rotational activity ablation combined with pulmonary vein isolation.

Kis Z, Theuns DA, Bhagwandien R, Wijchers S, Yap SC, Szili-Torok T.

J Cardiovasc Electrophysiol. 2017 Aug;28(8):862-869. doi: 10.1111/jce.13240. Epub 2017 Jun 21.

PMID:
28471019
23.

Questioning the preference for dual- vs. single-chamber implantable defibrillator in primary prevention implantable cardioverter-defibrillator recipients.

Kutyifa V, Theuns DAMJ.

Europace. 2017 Sep 1;19(9):1416-1417. doi: 10.1093/europace/euw288. No abstract available.

PMID:
28340137
24.

Comparison of Multivariate Risk Estimation Models to Predict Prognosis in Patients With Implantable Cardioverter Defibrillators With or Without Cardiac Resynchronization Therapy.

Akoudad S, Dabiri Abkenari L, Schaer BA, Sticherling C, Levy WC, Jordaens L, Theuns DA.

Am J Cardiol. 2017 May 1;119(9):1414-1420. doi: 10.1016/j.amjcard.2017.01.035. Epub 2017 Feb 10.

PMID:
28267958
25.

Incidence of Device-Detected Atrial Fibrillation and Long-Term Outcomes in Patients With Hypertrophic Cardiomyopathy.

van Velzen HG, Theuns DA, Yap SC, Michels M, Schinkel AF.

Am J Cardiol. 2017 Jan 1;119(1):100-105. doi: 10.1016/j.amjcard.2016.08.092. Epub 2016 Sep 29.

PMID:
28247846
26.

Web-based distress management for implantable cardioverter defibrillator patients: A randomized controlled trial.

Habibović M, Denollet J, Cuijpers P, van der Voort PH, Herrman JP, Bouwels L, Valk SD, Alings M, Theuns DA, Pedersen SS.

Health Psychol. 2017 Apr;36(4):392-401. doi: 10.1037/hea0000451. Epub 2017 Feb 13.

PMID:
28192003
27.

Performance of the subcutaneous implantable cardioverter-defibrillator in patients with a primary prevention indication with and without a reduced ejection fraction versus patients with a secondary prevention indication.

Boersma LV, Barr CS, Burke MC, Leon AR, Theuns DA, Herre JM, Weiss R, Kremers MS, Neuzil P, Husby MP, Carter N, Stivland TM, Gold MR; EFFORTLESS and IDE Study Investigators.

Heart Rhythm. 2017 Mar;14(3):367-375. doi: 10.1016/j.hrthm.2016.11.025. Epub 2016 Nov 24.

28.

Comparative study of the failure rates among 3 implantable defibrillator leads.

van Malderen SC, Szili-Torok T, Yap SC, Hoeks SE, Zijlstra F, Theuns DA.

Heart Rhythm. 2016 Dec;13(12):2299-2305. doi: 10.1016/j.hrthm.2016.08.001. Epub 2016 Aug 2.

PMID:
27496586
29.

A Comparison of the Quality of Life of Patients With an Entirely Subcutaneous Implantable Defibrillator System Versus a Transvenous System (from the EFFORTLESS S-ICD Quality of Life Substudy).

Pedersen SS, Mastenbroek MH, Carter N, Barr C, Neuzil P, Scholten M, Lambiase PD, Boersma L, Johansen JB, Theuns DA.

Am J Cardiol. 2016 Aug 15;118(4):520-6. doi: 10.1016/j.amjcard.2016.05.047. Epub 2016 May 28.

PMID:
27353211
30.

Non-sustained ventricular tachycardia in patients with congenital heart disease: An important sign?

Teuwen CP, Ramdjan TT, Götte M, Brundel BJ, Evertz R, Vriend JW, Molhoek SG, Reinhart Dorman HG, van Opstal JM, Konings TC, van der Voort P, Delacretaz E, Wolfhagen NJ, van Gastel V, de Klerk P, Theuns DA, Witsenburg M, Roos-Hesselink JW, Triedman JK, Bogers AJ, de Groot NM.

Int J Cardiol. 2016 Mar 1;206:158-63. doi: 10.1016/j.ijcard.2016.01.042. Epub 2016 Jan 6.

PMID:
26805391
31.

Evaluation of subcutaneous ICD early performance in hypertrophic cardiomyopathy from the pooled EFFORTLESS and IDE cohorts.

Lambiase PD, Gold MR, Hood M, Boersma L, Theuns DAMJ, Burke MC, Weiss R, Russo AM, Kääb S, Knight BP.

Heart Rhythm. 2016 May;13(5):1066-1074. doi: 10.1016/j.hrthm.2016.01.001. Epub 2016 Jan 6.

PMID:
26767422
32.

Longevity of implantable cardioverter defibrillators: a comparison among manufacturers and over time.

von Gunten S, Schaer BA, Yap SC, Szili-Torok T, Kühne M, Sticherling C, Osswald S, Theuns DA.

Europace. 2016 May;18(5):710-7. doi: 10.1093/europace/euv296. Epub 2015 Nov 25.

33.

Ventricular tachycardia in ischemic cardiomyopathy; a combined endo-epicardial ablation as the first procedure versus a stepwise approach (EPILOGUE) - study protocol for a randomized controlled trial.

Hendriks AA, Khan M, Geller L, Kardos A, de Vries LJ, Yap SC, Wijchers SA, Theuns DA, Szili-Torok T.

Trials. 2015 Oct 29;16:487. doi: 10.1186/s13063-015-1005-6.

34.

Infection and mortality after implantation of a subcutaneous ICD after transvenous ICD extraction.

Boersma L, Burke MC, Neuzil P, Lambiase P, Friehling T, Theuns DA, Garcia F, Carter N, Stivland T, Weiss R; EFFORTLESS and IDE Study Investigators.

Heart Rhythm. 2016 Jan;13(1):157-64. doi: 10.1016/j.hrthm.2015.08.039. Epub 2015 Sep 1.

35.

The learning curve associated with the introduction of the subcutaneous implantable defibrillator.

Knops RE, Brouwer TF, Barr CS, Theuns DA, Boersma L, Weiss R, Neuzil P, Scholten M, Lambiase PD, Leon AR, Hood M, Jones PW, Wold N, Grace AA, Olde Nordkamp LR, Burke MC; IDE and EFFORTLESS investigators.

Europace. 2016 Jul;18(7):1010-5. doi: 10.1093/europace/euv299. Epub 2015 Aug 31.

36.

The Effect of Elapsed Time from Myocardial Infarction on Mortality and Major Adverse Cardiac and Cerebrovascular Events in ICD Patients.

Bons LR, Dabiri-Abkenari L, VAN Domburg RT, Szili-Torok T, Zijlstra F, Theuns DA.

Pacing Clin Electrophysiol. 2015 Dec;38(12):1448-55. doi: 10.1111/pace.12739. Epub 2015 Oct 1.

PMID:
26289034
37.

Longevity of the Subcutaneous Implantable Defibrillator: Long-Term Follow-Up of the European Regulatory Trial Cohort.

Theuns DA, Crozier IG, Barr CS, Hood MA, Cappato R, Knops RE, Maass AH, Boersma LV, Jordaens L.

Circ Arrhythm Electrophysiol. 2015 Oct;8(5):1159-63. doi: 10.1161/CIRCEP.115.002953. Epub 2015 Jul 6.

PMID:
26148819
38.

Inappropriate shocks in the subcutaneous ICD: Incidence, predictors and management.

Olde Nordkamp LR, Brouwer TF, Barr C, Theuns DA, Boersma LV, Johansen JB, Neuzil P, Wilde AA, Carter N, Husby M, Lambiase PD, Knops RE.

Int J Cardiol. 2015 Sep 15;195:126-33. doi: 10.1016/j.ijcard.2015.05.135. Epub 2015 May 22.

PMID:
26026928
39.

Prolonged right ventricular ejection delay identifies high risk patients and gender differences in Brugada syndrome.

Van Malderen SC, Kerkhove D, Theuns DA, Weytjens C, Droogmans S, Tanaka K, Daneels D, Van Dooren S, Meuwissen M, Bonduelle M, Brugada P, Van Camp G.

Int J Cardiol. 2015 Jul 15;191:90-6. doi: 10.1016/j.ijcard.2015.04.243. Epub 2015 May 1.

PMID:
25965611
40.

Validation of the 2014 European Society of Cardiology guidelines risk prediction model for the primary prevention of sudden cardiac death in hypertrophic cardiomyopathy.

Vriesendorp PA, Schinkel AF, Liebregts M, Theuns DA, van Cleemput J, Ten Cate FJ, Willems R, Michels M.

Circ Arrhythm Electrophysiol. 2015 Aug;8(4):829-35. doi: 10.1161/CIRCEP.114.002553. Epub 2015 Apr 28.

PMID:
25922410
41.

Safety and Efficacy of the Totally Subcutaneous Implantable Defibrillator: 2-Year Results From a Pooled Analysis of the IDE Study and EFFORTLESS Registry.

Burke MC, Gold MR, Knight BP, Barr CS, Theuns DAMJ, Boersma LVA, Knops RE, Weiss R, Leon AR, Herre JM, Husby M, Stein KM, Lambiase PD.

J Am Coll Cardiol. 2015 Apr 28;65(16):1605-1615. doi: 10.1016/j.jacc.2015.02.047.

42.

Patients with congenital heart disease: how to determine the eligibility for implantation of a subcutaneous implantable defibrillator?

Crozier IG, Theuns DA.

Europace. 2015 Jul;17(7):1003-4. doi: 10.1093/europace/euv087. Epub 2015 Apr 2. No abstract available.

PMID:
25840290
43.

Air entrapment causing early inappropriate shocks in a patient with a subcutaneous cardioverter-defibrillator.

Yap SC, Bhagwandien RE, Szili-Torok T, Theuns DAMJ.

HeartRhythm Case Rep. 2015 Feb 25;1(3):156-158. doi: 10.1016/j.hrcr.2015.02.010. eCollection 2015 May. No abstract available.

44.

Trajectories of patient-reported health status in patients with an implantable cardioverter defibrillator.

Mastenbroek MH, Denollet J, Versteeg H, van den Broek KC, Theuns DA, Meine M, Zijlstra WP, Pedersen SS.

Am J Cardiol. 2015 Mar 15;115(6):771-7. doi: 10.1016/j.amjcard.2014.12.035. Epub 2015 Jan 6.

PMID:
25623734
45.

[Inappropriate ICD shocks after collision with a pole].

Yap SC, Theuns DA, Szili-Torok T.

Ned Tijdschr Geneeskd. 2015;159:A9642. Dutch.

PMID:
26980463
46.

A prospective study on safety of catheter ablation procedures: contact force guided ablation could reduce the risk of cardiac perforation.

Akca F, Janse P, Theuns DA, Szili-Torok T.

Int J Cardiol. 2015 Jan 20;179:441-8. doi: 10.1016/j.ijcard.2014.11.105. Epub 2014 Nov 13.

PMID:
25465303
47.

A comparison of the health status and psychological distress of partners of patients with a left ventricular assist device versus an implantable cardioverter defibrillator: a preliminary study.

Brouwers C, Caliskan K, de Jonge N, Theuns DA, Constantinescu A, Young QR, Cannon C, Denollet J, Pedersen SS.

Heart Lung. 2015 Jan-Feb;44(1):27-32. doi: 10.1016/j.hrtlng.2014.10.007. Epub 2014 Nov 20.

PMID:
25453389
48.

E-health to manage distress in patients with an implantable cardioverter-defibrillator: primary results of the WEBCARE trial.

Habibović M, Denollet J, Cuijpers P, Spek VR, van den Broek KC, Warmerdam L, van der Voort PH, Herrman JP, Bouwels L, Valk SS, Alings M, Theuns DA, Pedersen SS.

Psychosom Med. 2014 Oct;76(8):593-602. doi: 10.1097/PSY.0000000000000096.

PMID:
25264974
49.

Information provision, satisfaction and emotional distress in patients with an implantable cardioverter-defibrillator.

Hoogwegt MT, Widdershoven JW, Theuns DA, Pedersen SS.

Int J Cardiol. 2014 Dec 15;177(2):586-8. doi: 10.1016/j.ijcard.2014.08.150. Epub 2014 Aug 30. No abstract available.

PMID:
25220174
50.

Long-term mortality risk in patients with an implantable cardioverter-defibrillator: Influence of heart rate and QRS duration.

Hoogwegt MT, Theuns DA, Pedersen SS, Kupper N.

Int J Cardiol. 2014 Aug 20;175(3):560-4. doi: 10.1016/j.ijcard.2014.06.030. Epub 2014 Jun 28.

PMID:
25015024

Supplemental Content

Loading ...
Support Center